|
MAGE (mmol/L)
| |
<2.37
|
2.37-3.65
|
>3.65
|
P
|
|---|
|
Subject number (n)
|
237
|
80
|
78
|
79
|
NA
|
|
Composite MACE
|
35 (14.8)
|
6 (7.5)
|
11 (14.1)
|
18 (22.8)
|
0.025
|
|
Cardiac death
|
4 (1.7)
|
1 (1.3)
|
1 (1.3)
|
2 (2.5)
|
0.775
|
|
Reinfarction
|
3 (1.3)
|
0 (0)
|
1 (1.3)
|
2 (2.5)
|
0.361
|
|
Repeated TVR
|
3 (1.3)
|
0 (0)
|
1 (1.3)
|
2 (2.5)
|
0.361
|
|
Recurrent angina
|
15 (6.3)
|
3 (3.8)
|
5 (6.4)
|
7 (8.9)
|
0.416
|
|
Malignant arrhythmia
|
10 (4.2)
|
2 (2.5)
|
3 (3.8)
|
5 (6.3)
|
0.477
|
|
Non-cardiac death
|
1 (0.4)
|
0 (0)
|
1 (1.3)
|
0 (0)
|
0.359
|
|
Non-IRA revascularization
|
53 (22.4)
|
12 (15)
|
16 (21)
|
25 (32)
|
0.037
|
- Data given as mean ± SD or n (%).
- MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.
